Selective nanoparticle-directed ablation of the canine prostate

Lasers in Surgery and Medicine

Volumn 43, Issue 3, 2011, Pages 213-220

  Schwartz, Jon A ^a   Price, Roger E ^b   Gill Sharp, Kelly L ^a   Sang, Krystina L ^a   Khorchani, Jennifer ^a   Goodwin, Bradford S ^c   Payne, J Donald ^a  

^a Nanospectra Biosciences Inc   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer; Laser; Nanoshell; Optical fiber

Indexed keywords

GALLIUM ARSENIDE; GLASS FIBER; GOLD; GOLD NANOPARTICLE; MACROGOL; NANOSHELL; SILICON DIOXIDE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETER; CONTROLLED STUDY; DIODE LASER; DOG; DOSIMETRY; EQUIPMENT DESIGN; HISTOPATHOLOGY; LAPAROTOMY; MALE; NANOPARTICLE DIRECTED ABLATION THERAPY; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE TUMOR; SIMULATION;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, RADIATION; LASERS, SEMICONDUCTOR; MALE; NANOSHELLS; PILOT PROJECTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 79952757302     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21039     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures 2010. Atlanta: American Cancer Society; 2010.
2. Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L. Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol 2007;178(6):2260-2267. (Pubitemid 350052204)
3. Edmundson GK, Yan D, Martinez AA. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys 1995;33(5):1257-1263.
4. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. J Urol 2005;173(5):1701-1705. (Pubitemid 40524809)
5. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008;148(6):435-448. (Pubitemid 351665443)
6. Klotz LH, Nam RK. Active surveillance with selective delayed interventionfor favorable risk prostate cancer: Clinical experience and a 'number needed to treat' analysis. Can J Urol 2006;13(Suppl 1):48-55.
7. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M. Will focal therapy become a standard of care for menwith localized prostate cancer? Nat Clin Pract Oncol 2007;4(11):632-642.
8. Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 2006;97(1):56-61.
9. Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T, Satoh T. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006;13(3):228-233.
10. Thalmann GN, Mattei A, Treuthardt C, Burkhard FC, Studer UE. Transurethral microwave therapy in 200 patients with a minimum follow up of 2 years: Urodynamic and clinical results. J Urol 2002;167(6):2496-2501. (Pubitemid 34533155)
11. Giebeler A, Fontenot J, Balter P, Ciangaru G, Zhu R, Newhauser W. Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer. J Appl Clin Med Phys 2009;10(1):2875.
12. Yepes P, Randeniya S, Taddei PJ, Newhauser WD. Monte Carlo fast dose calculator for proton radiotherapy: Application to a voxelized geometry representing a patient with prostate cancer. Phys Med Biol 2009;54(1):N21-N228.
13. Ishida O, Maruyama K, Sasaki K, Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 1999;190(1):49-56. (Pubitemid 29467471)
14. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001;41:189-207.
15. Stern JM, Stanfield J, Kabbani W, Hsieh JT, Cadeddu JA. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 2008;179(2):748-753.
16. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004;209(2):171-176. (Pubitemid 38670486)
17. Schwartz JA, Shetty AM, Price RE, Stafford RJ, Wang JC, Uthamanthil RK, Pham K, McNichols RJ, Coleman CL, Payne JD. Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. Cancer Res 2009;69(4):1659-1667.
18. Cromeens DM, Johnson DE, Stephens LC, Gray KN. Visual laser ablation of the canine prostate with a diffusing fiber and an 805-nanometer diode laser. Lasers Surg Med 1996;19(2):135-142. (Pubitemid 26327972)
19. Johnson DE, Price RE, Cromeens DM. Pathologic changes occurring in the prostate following transurethral laser prostatectomy. Lasers Surg Med 1992;12(3):254-263.
20. Hazle JD, Diederich CJ, Kangasniemi M, Price RE, Olsson LE, Stafford RJ. MRI-guided thermal therapy of transplanted tumorsin the canine prostate using a directional transurethral ultrasound applicator. J Magn Reson Imaging 2002;15(4):409-417. (Pubitemid 34252403)
21. Cole JR, Mirin NA, Knight MW, Goodrich GP, Halas NJ. Photothermal efficiencies of nanoshells and nanorods for clinical therapeutic applications. J Phys Chem C 2009;113(28):12090-12094.
22. Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: Various factors, mechanisms involved and its implications. Int Immunopharmacol 2003;3(3):319-328. (Pubitemid 36293960)
23. Kassouf W, Brown GA, Shetty A, Hazle JD, Stafford RJ, Rosser CJ, Stephens C, Tinkey PT, Pisters LL. An in vivo orthotopic canine model to evaluate distribution of intra prostatic injectate: Implications for gene therapy and drug delivery for prostate cancer. Urology 2007;70(4):822-825. (Pubitemid 350030223)
24. James WD, Hirsch LR, West JL, O'Neal DP, Payne JD. Application of INAA to the build-up and clearance of gold nanoshells in clinical studies in mice. J Radioanal Nucl Chem 2007;271(2):455-459. (Pubitemid 44915453)